Insider Selling: Ryan Specialty Holdings, Inc. (NYSE:RYAN) Director Sells 35,000 Shares of Stock

Ryan Specialty Holdings, Inc. (NYSE:RYAN) Director Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock in a transaction on Tuesday, January 21st. The shares were sold at an average price of $66.35, for a total value of $2,322,250.00. Following the transaction, the director now owns 20,909 shares in the company, valued at $1,387,312.15. This represents a 62.60 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website.

Nicholas Dominic Cortezi also recently made the following trade(s):

• On Friday, January 17th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The stock was sold at an average price of $67.15, for a total value of $2,350,250.00.
• On Wednesday, January 15th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The stock was sold at an average price of $65.99, for a total transaction of $2,309,650.00.
• On Monday, January 13th, Nicholas Dominic Cortezi sold 29,466 shares of Ryan Specialty stock. The shares were sold at an average price of $65.06, for a total transaction of $1,917,057.96.
• On Friday, December 20th, Nicholas Dominic Cortezi sold 91 shares of Ryan Specialty stock. The shares were sold at an average price of $65.00, for a total transaction of $5,915.00.
• On Wednesday, December 18th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The stock was sold at an average price of $65.17, for a total value of $2,280,950.00.
• On Monday, December 16th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The stock was sold at an average price of $66.71, for a total value of $2,334,850.00.
• On Friday, December 13th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The shares were sold at an average price of $67.39, for a total value of $2,358,650.00.

Ryan Specialty Price Performance

NYSE RYAN traded up $0.13 during trading on Tuesday, reaching $66.73. 768,093 shares of the company traded hands, compared to its average volume of 1,051,816. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.01 and a current ratio of 1.01. The company has a market cap of $17.47 billion, a price-to-earnings ratio of 86.66, a P/E/G ratio of 1.19 and a beta of 0.72. Ryan Specialty Holdings, Inc. has a 1-year low of $42.21 and a 1-year high of $75.97. The stock’s 50 day moving average price is $67.84 and its two-hundred day moving average price is $66.06.

Ryan Specialty (NYSE:RYAN) last released its quarterly earnings results on Wednesday, October 30th. The company reported $0.41 EPS for the quarter, meeting analysts’ consensus estimates of $0.41. Ryan Specialty had a net margin of 10.31% and a return on equity of 47.90%. The firm had revenue of $604.69 million for the quarter, compared to analyst estimates of $602.04 million. During the same period in the previous year, the business earned $0.32 earnings per share. The company’s revenue for the quarter was up 20.5% compared to the same quarter last year. As a group, analysts anticipate that Ryan Specialty Holdings, Inc. will post 1.82 EPS for the current year.

Ryan Specialty Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, November 26th. Shareholders of record on Tuesday, November 12th were given a $0.11 dividend. This represents a $0.44 annualized dividend and a yield of 0.66%. The ex-dividend date was Tuesday, November 12th. Ryan Specialty’s payout ratio is presently 57.14%.

Hedge Funds Weigh In On Ryan Specialty

Large investors have recently modified their holdings of the stock. Hollencrest Capital Management bought a new position in Ryan Specialty in the 3rd quarter worth approximately $25,000. Assetmark Inc. acquired a new stake in shares of Ryan Specialty in the 3rd quarter valued at $34,000. Quarry LP raised its position in shares of Ryan Specialty by 109.3% during the third quarter. Quarry LP now owns 808 shares of the company’s stock worth $54,000 after acquiring an additional 422 shares during the last quarter. GAMMA Investing LLC lifted its stake in shares of Ryan Specialty by 106.4% during the third quarter. GAMMA Investing LLC now owns 1,249 shares of the company’s stock valued at $83,000 after acquiring an additional 644 shares during the period. Finally, Signaturefd LLC raised its holdings in Ryan Specialty by 12.3% during the 3rd quarter. Signaturefd LLC now owns 1,347 shares of the company’s stock worth $89,000 after purchasing an additional 148 shares during the last quarter. 84.82% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on the stock. Bank of America lifted their target price on shares of Ryan Specialty from $75.00 to $84.00 and gave the company a “buy” rating in a research note on Thursday, October 10th. Morgan Stanley started coverage on shares of Ryan Specialty in a report on Thursday, December 5th. They issued an “overweight” rating and a $90.00 price objective for the company. BMO Capital Markets upgraded Ryan Specialty from a “market perform” rating to an “outperform” rating and raised their target price for the company from $65.00 to $75.00 in a report on Tuesday, September 24th. Wells Fargo & Company lowered their target price on shares of Ryan Specialty from $68.00 to $64.00 and set an “equal weight” rating on the stock in a research note on Tuesday, January 14th. Finally, Barclays lifted their price target on Ryan Specialty from $76.00 to $88.00 and gave the stock an “overweight” rating in a research report on Thursday, November 21st. One research analyst has rated the stock with a sell rating, five have given a hold rating and six have issued a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $74.40.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.